Sign in

Dr Lauren Byrne

@drl-bo.bsky.social
74 followers 81 following 1 posts

Principal investigator of @hob-lab.bsky.social at @ucl-hd.bsky.social. HD researcher and family advocate. Opinions are my own.

PostsRepliesMedia
Reposted by Dr Lauren Byrne
House of Byrne Lab @hob-lab.bsky.social · 14/07/2025
Here's an open access link to full text of our paper shared last week! rdcu.be/evKF9
rdcu.be
Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases
033
Reposted by Dr Lauren Byrne
Selina Wray @selinawray.bsky.social · 14/07/2025
UCL Queen Square Institute of Neurology ready to (platform) party this morning! @uclqsion.bsky.social Huge congratulations to all of our graduates from the @uclbrainscience.bsky.social & wishing you all every success for the future! #UCLgrad
0145
Reposted by Dr Lauren Byrne
Rachael Scahill @rachiscahill.bsky.social · 11/07/2025
Important paper on accessible biomarkers from @hob-lab.bsky.social. Well done Annabelle Coleman @drl-bo.bsky.social and all.
075
Reposted by Dr Lauren Byrne
Dervis Salih @dervissalih1.bsky.social · 11/07/2025
Happy to have played a small part in testing this next generation of blood biomarker tests across different dementias: Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
alz-journals.onlinelibrary.wiley.com
Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis
INTRODUCTION Diagnosing Alzheimer's disease (AD) is challenging due to overlapping symptoms with other dementias and the invasiveness of current biomarkers. This study introduces the NULISA platform...
0123
Reposted by Dr Lauren Byrne
UCL Huntington’s Disease Centre @ucl-hd.bsky.social · 10/07/2025
New paper from the @hob-lab.bsky.social just published in Journal of Neurology. A step toward more accessible biomarker testing 🩸 link.springer.com/article/10.1... @drl-bo.bsky.social @uclbrainscience.bsky.social @uclqsion.bsky.social
link.springer.com
Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases - Journal of Neurology
Promising blood-based biomarkers of neuropathology have emerged with potential for therapeutic development and disease monitoring. However, these tools will require specialist tertiary services for in...
058
Dr Lauren Byrne @drl-bo.bsky.social · 10/07/2025
I am unbelievably proud to have my first senior author paper published today! It was a long slog through multiple review cycles but we got there! A big thank you to my lab members and all the collaborators and participants who contributed to this work! 🥲
084
Reposted by Dr Lauren Byrne
HDClarity @hdclaritystudy.bsky.social · 04/06/2025
Where else are we planning to open HDClarity sites? We are currently in the process of opening recruitment to the study into other countries, including Melbourne, Australia, and Lisbon, Portugal.
112
Reposted by Dr Lauren Byrne
UCL News @uclnews.bsky.social · 10/06/2025
A series of digital tests carried out via a smartphone app could enhance the detection of disease progression in #HuntingtonsDisease and improve the efficiency of clinical trials, finds research led by scientists at @uclqsion.bsky.social @ucl-hd.bsky.social and Roche including @profwild.bsky.social
ucl.ac.uk
Smartphone tests could accelerate drug development for Huntington’s disease
A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials, finds research le...
085
Reposted by Dr Lauren Byrne
Prof Ed Wild @profwild.bsky.social · 10/06/2025
New paper in BRAIN from Team Wild and Roche: A digital motor score for sensitive detection of progression in Huntington’s disease (open access) doi.org/10.1093/brai...
doi.org
A digital motor score for sensitive detection of progression in Huntington’s disease
Giboin et al. introduce a new motor score that can be used to monitor Huntington’s disease progression. Co-designed by people with Huntington’s disease and
044